Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_1267_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Foreword
- •Foreword
- •Contents
- •References
- •2.1 Introduction
- •2.2.1 Crohn’s Disease
- •2.2.2 Ulcerative Colitis
- •References
- •3.2.1 Bacterial Sensing
- •3.2.1.2 Toll-Like Receptors, TLRs
- •3.2.2 Autophagy: Autophagy-Related 16-like 1, ATG16L1
- •3.1 Introduction
- •3.2.4.1 Interleukin-23 Receptor, IL-23R
- •3.2.4.2 Fractalkine Receptor 1, CX3CR1
- •3.2.4.3 Transforming Growth Factor Beta (TGF-β)
- •3.2.4.4 Angiotensinogen
- •3.2.4.5 Tumour Necrosis Factor Alpha (TNFα)
- •3.2.6 Cell Signalling: Janus Kinase 2 (JAK2)
- •3.2.8 Other Processes
- •References
- •4.1 Introduction
- •4.2 Genetics
- •4.3 Epigenetics
- •4.5 DNA Methylation
- •4.9 MicroRNA
- •4.12 Summary
- •References
- •5.1 Introduction
- •5.2.1 TNFα
- •5.2.2 Th1 Cytokines
- •5.2.3 IL-1 Cytokines
- •5.2.4 Th2 Cytokines
- •5.2.5 Th17 Cytokines
- •5.2.6 TL1A
- •5.3 “Regulatory” Cytokines
- •5.3.1 TGFβ
- •5.3.2 IL-10
- •5.4 Concluding Remarks
- •References
- •6.1.1.1 Collagens
- •6.1.1.3 Glycoproteins
- •6.2.1 Integrins
- •6.3.1 Extracellular Matrix Stiffness
- •6.3.1.1 Modeling Extracellular Matrix Stiffness
- •References
- •7.1 Introduction
- •7.5 Future Outlook
- •References
- •8.1 Introduction
- •8.2.1 Smoking
- •8.3 Conclusion
- •References
- •9.4 Conclusions
- •References
- •10.1 Ulcerative Colitis
- •10.1.1 Epidemiology
- •10.1.2 Etiology
- •10.2.1 Pathogenesis
- •References
- •11.4 Conclusion
- •References
- •12.1 Introduction
- •12.2 Clinical Biomarkers
- •12.3 Cellular Biomarkers
- •12.4 Serologic Biomarkers
- •12.5 Other Factors
- •12.6 Conclusions
- •References
- •13.1 Introduction
- •13.3 Bowel Ultrasound
- •13.4 Computed Tomography Enterography
- •13.5 Magnetic Resonance Imaging
- •13.5.2 Functional MR Imaging Techniques
- •13.5.3 Hybrid Imaging Techniques
- •13.6 Conclusion
- •References
- •14.1.1 Ultrasound Stiffness Imaging
- •14.1.2 Shear Wave Elastography
- •14.5 Conclusion
- •References
- •15.1 Introduction
- •15.2.1 Stricturing IBD
- •15.2.2 Stricturing CD
- •15.2.3 Stricturing UC
- •15.4.1 Steroids
- •15.4.2 5-ASA
- •15.4.3 Purine Analogs
- •15.4.4 Methotrexate
- •15.4.5 Anti-TNFs
- •15.4.6 Other Biologics
- •15.5 Other Measures
- •15.6 Conclusion
- •References
- •16.1 Introduction
- •17.2.4 Abscess
- •17.3 Stricturoplasty or Resection
- •17.4 Approach
- •16.6 Conclusion
- •References
- •17.1 Introduction
- •17.2.2 Fibrotic Phenotype
- •17.2.3 Fistulising Disease
- •17.4.1 Open
- •17.4.2 Handassisted
- •17.4.3 Multi-Port
- •17.4.4 Single-Port
- •17.4.5 Single Port versus Multi-Port
- •17.4.6 Decision Making
- •17.5 Anastomosis
- •17.7 Conclusion
- •References
- •18.1 Introduction
- •18.4.1 Initial Evaluation
- •18.5.1 Pre-IPAA (Afferent Limb/Ileostomy Closure Site)
- •18.5.2 The Fibrotic IPAA Body
- •18.5.3 Post-IPAA (Efferent Limb, Anal Canal)
- •18.6 Conclusion
- •References
- •19.2 Pathophysiology
- •19.3 Diagnosis
- •19.4 Surgical Approach
- •19.4.1 Resections
- •19.4.2 Strictureplasties
- •19.4.2.1 History
- •19.4.2.2 Indications
- •19.4.2.3 General Technique
- •19.4.2.4 Conventional Strictureplasties
- •Judd Strictureplasty
- •Moskel-Walske-Neumayer Strictureplasty
- •Jaboulay Strictureplasty
- •Poggioli Strictureplasty
- •19.4.2.6 Results
- •Short-Term Results
- •Long-Term Results
- •19.5 Future Perspectives
- •References
- •20.1 Introduction
- •20.6 Summary
- •References
- •21.1 Introduction
- •21.2 Wound Healing
- •21.3 Crohn’s Disease Fistula
- •21.7 Summary
- •References
- •22.1 Introduction
- •22.3 The Transforming Growth Factor-β (TGF-β) Pathways
- •22.4.1 Connective Tissue Growth Factor (CTGF/CCN2)
- •22.4.2 Platelet Derived Growth Factor
- •22.4.3 Wnt-Signaling
- •22.4.4 Hedgehog Signaling
- •22.4.5 Notch Signaling
- •22.6.1 Coagulation Stage
- •22.6.3 Fibrous Adhesion Stage
- •22.7.4 Material Barriers
- •22.7.5 Pharmaceutical Approaches
- •22.8.4 Smooth Muscle Cells
- •22.12 Conclusions
- •References
- •23.1 Introduction
- •23.2 Liver
- •23.2.1 Farnesoid X Receptor (FXR)
- •23.2.2 Lysyl Oxidase (LOXL2)
- •23.2.3 Statins
- •23.2.4 5-Hydroxytryptamine (5HT)
- •23.2.5 Caspase Inhibition
- •23.2.6 Chemokine Receptors CCR2/5
- •23.2.7 GR-MD-02
- •23.2.8 PPAR Gamma
- •23.3 Lung
- •23.3.1 Pirfenidone
- •23.3.2 Nintedanib/Tyrosine Kinase Inhibitors
- •23.3.3 Lysophospholipids
- •23.3.4 mTOR
- •23.3.5 Prostacyclin
- •23.3.6 Integrin αvβ6
- •23.3.7 Endothelin Receptor Antagonism
- •23.3.8 Interleukin (IL)-13
- •23.3.9 Connective Tissue Growth Factor
- •23.3.10 Serum Amyloid P
- •23.4 Kidney
- •23.4.2 Pyridoxamine
- •23.4.3 Janus Kinase (JAK)1/2
- •23.4.4 Bindarit-CCL (MCP) Inhibitor
- •23.4.5 Phosphodiesterase Inhibition
- •23.5 Skin
- •23.5.1 TGFβ Targeted Therapies
- •23.5.2 Thalidomide/Pomalidomide
- •23.5.3 Paquinimod
- •23.6 Heart
- •23.6.1 Renin Angiotensin Aldosterone System (RAAS)
- •23.6.2 Transforming Growth Factor (TGF)-β
- •23.7 Conclusion
- •References
- •Index

17 Resectional Surgery forIntestinal Strictures: What Is State oftheArt?
can also vary between facilitated laparoscopic, laparoscopic assisted, and total laparoscopic approaches. Facilitated laparoscopy includes the combination of laparoscopic and open approach: only mobilisation of the bowel is done laparoscopically.
Subsequently, the vascular ligation, bowel transection, and anastomosis creation is
done in an open fashion. In the laparoscopic assisted approach mobilisation and
vascular division is done laparoscopically, and anastomosis creation is done outside
the body. Finally, in the total laparoscopic approach all phases of the operation are
done laparoscopically.
239
17.4.1 Open
Multiple factors are linked to using the open approach. One hard indication of open
surgery is multiple prior open operations with extensive adhesions. However, the
benets of laparoscopic surgery for IBD with regards to short- and long-term morbidity, including safety, efcacy, reduced postoperative complication, earlier recovery, and superior body image and cosmetics, are extensively reported and are now
established [60–63]. Therefore, laparoscopic ileocolic resection is considered the
preferred approach for strictures, as long as appropriate expertise is available.
Ultimately, a good open operation is better than a bad laparoscopic one.
17.4.2 Handassisted
Indication for handassisted surgery are stulas of the terminal ileum to bladder,
vagina and sigmoid. Using a handport located in a Pfannenstiel position, the stulas
can safely be disconnected, followed by a handport mobilisation of the right colon.
Furthermore, extraction of a more sizable specimens and inammatory masses is
possible with handassistance, without converting to an open approach. In this way,
cosmetics and incisional hernia rates can be compromised [64].
17.4.3 Multi-Port
Straight laparoscopic surgery via multi-port for Crohn’s disease was rst reported
in 1992 [65]. For multi-port ileocolic resections, a camera port is introduced at the
site of the umbilicus. Additionally, 2 or 3 ports are placed. Mobilisation of the right
colon and the terminal ileum is performed from lateral to medial or medial to lateral. The ileocolic anastomosis can be done extra- or intracorporeally. The specimen can be extracted through the umbilical incision by extending the umbilical
port access or via a Pfannenstiel suprapubic incision, in case of a larger inammatory mass.

240
K. A. T. G. M. Wasmann et al.
17.4.4 Single-Port
The single-port technique was rst described in 2008 to further reduce the invasiveness of the procedure by avoiding additional port sites [66, 67]. Single port ileocolic
resections are performed using a port positioned at the umbilicus, suprapubically, or
at the planned stoma site. This site also functions as the extraction site. Regular
straight laparoscopic instruments can be used. Mobilisation of the ascending colon
can be performed either from lateral to medial or the other way around, according
to the surgeon’s preference. Again, the ileocolic anastomosis can be done extra- or
intracorporeally. Some surgeons put the port suprapubically avoiding an incision in
the umbilicus. The prerequisite of single port surgery is that the size of the specimen
is relatively small in order to keep the skin incision within the limits of the umbilical
folds. Technically, this can be done by a close bowel transection of the mesentery
reducing the size of the specimen.
17.4.5 Single Port versus Multi-Port
Single port technique decreases the abdominal trauma by reducing the number of
incision sites. Patients undergoing a single port report less postoperative pain with a
reduction of the need for analgesics (including opiates) compared to multi-port
patients [68]. Regarding postoperative complication, conversion rates to open surgery, and need of stoma creation, no differences between single port and multi-port
are recorded. The main advantage of single port ileocolic resection over multi-port
is the superior cosmesis limiting the number of scars to one at the umbilicus
(Fig.17.1). Therefore, it represents the ideal surgical approach in predominantly
Fig. 17.1 Single port at
umbilicus

17 Resectional Surgery forIntestinal Strictures: What Is State oftheArt?
young CD patients with strong consideration to preserve the body image. Obviously,
fewer incisional hernias will occur since single port surgery does not require additional trocar sites. When the single port is placed in the future stoma site, an increase
in parastomal hernias has been described, due to enlargement of the stoma site to
facilitate the single port and the specimen extraction [69]. It must be stressed, that if
single port is difcult, there is no argument against the later insertion of one or two
additional trocars or a conversion to multi-port.
241
17.4.6 Decision Making
The approach and type of surgery depends on disease characteristics (e.g. size of the
inammatory mass), multiple locations, patient characteristics (e.g. prior surgeries),
and surgical characteristics (e.g. surgeon’s preference and expertise). Preoperative
imaging of the inammatory process must guide the surgeon towards either open
surgery or laparoscopic surgery with specimen extraction via umbilicus or
Pfannenstiel incision. Sizable masses or stula towards pelvic organs are best
approached via a laparoscopic procedure with a Pfannenstiel incision as the extraction site, whereas the umbilical up and down incision is more suitable for limited
masses. It is generally accepted that single-port surgery is more difcult to perform,
due to a decrease in the range of motion for the surgeon. In case preoperative imaging was not informative to assist in deciding the best approach, it’s recommended to
start with a diagnostic laparoscopy via the umbilicus and decide the most optimal
approach during surgery [70] (Fig.17.2).
17.5 Anastomosis
For ileocolic resections four different types of anastomostic congurations are used:
side-to-side isoperistaltic anastomosis, side-to-side anisoperistaltic anastomosis,
end-to-side anastomosis, and end-to-end anastomosis (Figs.17.3, 17.4, 17.5, 17.6,
and 17.7). Side-to-side (S-S) anastomosis can either be performed by the use of a
stapler or handsewn, and end-to-side (E-S) and end-to-end (E-E) only by handsewn.
Handsewn anastomosis can be performed as a single-layer or a two-layer anastomosis, depending on the preference of the surgeon. S-S anastomosis consist of isoperistaltic and anisoperistaltic anastomosis. In isoperistaltic anastomosis the fecal
stream remains in the original direction (functional end-to-end anastomosis),
whereas anisoperistaltic anastomosis interfere with the fecal stream. Grossly, the
isoperistaltic stapled S-S is done by close stapling of the resection margins, followed by resection of a corner of the resection line to pass the stapler and construct
a S-S anastomosis (Fig.17.3). Anisoperistaltic stapled S-S is done by enterotomies
of the resection margins, next the stapler is passed through both enterotomies to
create a S-S anastomosis (Fig. 17.4). The observation that recurrence almost

242
Fig. 17.2 Patient before
and after single port
ileocolic surgery
K. A. T. G. M. Wasmann et al.
Fig. 17.3 Isoperistaltic
S-S handsewn [71]

17 Resectional Surgery forIntestinal Strictures: What Is State oftheArt?
Fig. 17.4 Anisoperistaltic
S-S handsewn
243
Fig. 17.5 Anisoperistaltic
S-S stapled

244
Fig. 17.6 S-E handsewn
Fig. 17.7 E-E handsewn
K. A. T. G. M. Wasmann et al.
invariably appears at the anastomotic site, has led to the assumption that the type of
anastomosis could matter. In the literature, predominantly data comparing S-S versus E-E exist. Two studies, including one RCT, showed superiority of stapled anastomosis for anastomotic leakage. For surgical recurrence only a trend of delayed

17 Resectional Surgery forIntestinal Strictures: What Is State oftheArt?
surgical recurrence compared to handsewn anastomoses was observed [72, 73].
Usually, S-S is a wider anastomosis compared to an E-E anastomosis, less resistance suggests S-S would lead to less complication and postoperative recurrence.
This hypotheses was supported for short term outcomes in four meta-analyses, as
S-S anastomosis reduced overall postoperative complications and anastomotic leakage rate, compared to handsewn E-E anastomosis [58, 73–75]. One of the metaanalyses specically compared stapled isoperistaltic S-S versus handsewn E-E and
reported superiority of the S-S anastomosis for short term-outcomes [75]. This has
not been conrmed in RCT’s, reporting similar surgical outcomes, e.g. anastomotic
leakage rates, for stapled S-S anastomosis and handsewn E-E anastomosis [76, 77].
Concerning long-term effects, it is hypothesized that a higher resistance to the fecal
stream is associated with a higher recurrence rate. Probably all four techniques have
a different resistance to the fecal stream, either due to the width of the anastomosis
or due to the anti- or isoperistaltic direction. Therefore, the existing evidence directs
the surgeon towards using a wide anastomosis of which the aniso- and isoperistaltic
anastomosis are the best in this respect [74, 75]. The disadvantages of anisoperitaltic anastomoses are difcult intubation by colonoscopy, and of isoperistaltic anastomoses the creation of a blind loop on both sides of the anastomosis. Taken these
studies together with the practical consideration, aniso- or isoperistaltic stapled S-S
anastomosis are the preferred types of anastomosis.
245
17.6 Extent ofResection
Considering the relapsing entity of CD and the risk of short bowel syndrome
caused by multiple resections, guidelines advise limited ileocolic resections of
macroscopically involved bowel [78]. However, conicting ndings regarding the
clinical relevance of inammation-free resection margins, and new insights into
the possible role of the mesentery in recurrent disease and the extent of an ileocolic
resection with respect to transection of bowel and mesentery is currently a topic of
great interest.
17.6.1 Level ofBowel Transection
Guidelines are based on studies showing no prognostic value of inamed resection
margins, and a RCT demonstrating no difference in extensive vs. limited ileocolic
resection [79–81]. So far microscopic positive section margins are accepted as of no
importance concerning recurrence. A recent cohort study identied disease activity
at resection margins as an independent risk factor for CD recurrence [48]. But, it
was difcult to draw clinical conclusions, as no uniform pathological denitions
were used. Recently, a study was performed that microscopically analyzed the proximal (ileum) and distal (colon) resection margin separately. Inammation at the
colonic resection margin, and not the ileal site, was associated to increase clinical

246
recurrence (K.A. Wasmann etal., submitted). This could explain previous discrepancy, as until now the discussion was focussed on the proximal resection margin.
However, further research and validation studies are necessary to nally elucidate
the clinical consequence of a positive ileum or colon resection margin.
K. A. T. G. M. Wasmann et al.
17.6.2 Extent ofResection ofMesentery
In benign IBD surgery the mesentery is spared and typically taken close to the
bowel wall. Increasing evidence shows that the mesentery plays an active role in
the pathophysiology of Crohn’s disease (it is hypothesized that it is an participant
in the pathogenesis of bro-inammatory and pure brotic stenosis) [82–84]. In
ulcerative colitis close rectal dissection with preservation of the mesorectum versus
total mesorectal excision in ileal pouch-anal anastomosis reduces anastomotic
leakage and improves quality of life [85]. In contrast, a study comparing postoperative outcomes in close rectal dissection versus total mesorectal excision proctectomy for therapy-refractory Crohn’s disease, leaving the mesorectum in situ,
resulted in more perianal complications and decreased perianal healing (E. de
Groof etal., submitted) [86]. Moreover, analyzing the mesorectum after close rectal dissection, ongoing pro-inammatory characteristics could be demonstrated.
Although not established yet in clinical studies, it could be hypothesized that a
more extended resection of the mesentery reduces postoperative recurrence. The
question, if extended ‘oncological’ mesenteric resection, could reduce recurrence
is currently addressed in two RCT’s (NCT02542904, and A.Lightner, 2017, open
for inclusion).
17.7 Conclusion
In conclusion, clear indications for surgery of Crohn’s disease of the terminal
ileum are patients with pure brotic strictures, patients with symptomatic stulising disease and most of the patients with abscesses. Patients not responding to
anti- inammatory therapy and immunomodulators, and having a combination of
inammation and brotic stricture should be counselled for both medical (antiTNF) and surgical therapy. This decision making must be done together with the
patient (shared decision making). Furthermore, with the validation of a classication of Crohn’s disease in the terminal ileum per phenotype (bro-inammatory
disease, pure brotic disease, stulising disease, and stulising disease with
abscess formation) standardized care per phenotype could be achieved. An RCT is
recommended to determine the role of stricturoplasty over the valve compared to
surgical resection for Crohn’s disease in the terminal ileum. For ileocolic resection, eligible patients should undergo single port surgery with and stapled S-S
anastomosis. As stated before, surgery is not a cure for stricturing Crohn’s disease.

17 Resectional Surgery forIntestinal Strictures: What Is State oftheArt?
247
The 5-year clinical recurrence of surgery for bro-inammatory, pure brotic, stulizing, and stulizing with abscess disease, is up to 45%, and the 10-year surgical
recurrence is approximately 20% [1, 48, 87]. Recurrence rate per phenotype have
not been described yet. After ileocolic resection for all four phenotypes, postoperative recurrence at the anastomosis is the most common site. Conventional risk
factors for postoperative recurrence are smoking, prior intestinal surgery, and
absence of prophylactic treatment [78]. Studies analysing risk factors in resection
margins and mesentery could determine the most effective extent of resection in
Crohn’s disease.
References
1. Peyrin-Biroulet L, Loftus EV, Colombel J-F, Sandborn WJ.The natural history of adult Crohn’s
disease in population-based cohorts. Am J Gastroenterol. 2010;105(2):289–97. https://doi.
org/10.1038/ajg.2009.579. [cited 2017 May 23].
2. Cosnes J, Cattan S, Blain A, Beaugerie L, Carbonnel F, Parc R, etal. Long-term evolution of
disease behavior of Crohn’s disease. Inamm Bowel Dis. 2002;8(4):244–50. http://www.ncbi.
nlm.nih.gov/pubmed/12131607. [cited 2017 Jun 29].
3. Cosnes J, Gowerrousseau C, Seksik P, Cortot A.Epidemiology and natural history of inam-
matory bowel diseases. Gastroenterology. 2011;140(6):1785–94.
4. Papi C, Festa V, Fagnani C, Stazi A, Antonelli G, Moretti A, et al. Evolution of clinical
behaviour in Crohn’s disease: predictive factors of penetrating complications. Dig Liver Dis.
2005;37(4):247–53. http://www.ncbi.nlm.nih.gov/pubmed/15788208. [cited 2017 Jun 29].
5. Beaugerie L, Seksik P, Nion–Larmurier I, Gendre J, Cosnes J.Predictors of Crohn’s disease.
Gastroenterology. 2006;130(3):650–6. http://www.ncbi.nlm.nih.gov/pubmed/16530505.
[cited 2017 Jun 29].
6. Louis E, Collard A, Oger AF, Degroote E, Aboul Nasr El Ya FA, Belaiche J. Behaviour of
Crohn’s disease according to the Vienna classication: changing pattern over the course of
the disease. Gut. 2001;49(6):777–82. http://www.ncbi.nlm.nih.gov/pubmed/11709511. [cited
2017 Jul 18].
7. Satsangi J, Silverberg MS, Vermeire S, Colombel J-F.The Montreal classication of inam-
matory bowel disease: controversies, consensus, and implications. Gut. 2006;55(6):749–53.
http://www.ncbi.nlm.nih.gov/pubmed/16698746. [cited 2017 May 3].
8. Thia KT, Sandborn WJ, Harmsen WS, Zinsmeister AR, Loftus EV. Risk factors associ-
ated with progression to intestinal complications of Crohn’s disease in a population-based
cohort. Gastroenterology. 2010;139(4):1147–55. http://linkinghub.elsevier.com/retrieve/pii/
S0016508510010395. [cited 2017 Jun 6].
9. Solberg IC, Vatn MH, Høie O, Stray N, Sauar J, Jahnsen J, et al. Clinical course in Crohn’s
disease: results of a Norwegian population-based ten-year follow-up study. Clin Gastroenterol
Hepatol. 2007;5(12):1430–8. http://linkinghub.elsevier.com/retrieve/pii/S1542356507008889.
[cited 2017 Jul 19].
10. Wolters FL, Russel MG, Sijbrandij J, Ambergen T, Odes S, Riis L, etal. Phenotype at diag-
nosis predicts recurrence rates in Crohn’s disease. Gut. 2006;55(8):1124–30. https://doi.
org/10.1136/gut.2005.084061. [cited 2017 Jul 19].
11. Panés J, Bouzas R, Chaparro M, García-Sánchez V, Gisbert JP, Martínez de Guereñu B,
et al. Systematic review: the use of ultrasonography, computed tomography and magnetic
resonance imaging for the diagnosis, assessment of activity and abdominal complications of
Crohn’s disease. Aliment Pharmacol Ther. 2011;34(2):125–45. http://www.ncbi.nlm.nih.gov/
pubmed/21615440. [cited 2017 Jun 6].

248
12. Panes J, Bouhnik Y, Reinisch W, Stoker J, Taylor SA, Baumgart DC, etal. Imaging techniques
for assessment of inammatory bowel disease: joint ECCO and ESGAR evidence- based
consensus guidelines. J Crohns Colitis. 2013;7(7):556–85. http://www.ncbi.nlm.nih.gov/
pubmed/23583097. [cited 2017 Jun 6].
13. Fiorino G, Bonifacio C, Peyrin-Biroulet L, Minuti F, Repici A, Spinelli A, etal. Prospective
comparison of computed tomography enterography and magnetic resonance enterography
for assessment of disease activity and complications in ileocolonic Crohn’s disease. Inamm
Bowel Dis. 2011;17(5):1073–80. http://content.wkhealth.com/linkback/openurl?sid=WKPTL
P:landingpage&an=00054725-201105000-00002. [cited 2017 Jul 21].
14. Lautenbach E, Berlin JA, Lichtenstein GR.Risk factors for early postoperative recurrence
of Crohn’s disease. Gastroenterology. 1998;115(2):259–67. http://www.ncbi.nlm.nih.gov/
pubmed/9679030. [cited 2017 Jul 21].
15. Sachar DB, Subramani K, Mauer K, Rivera-MacMurray S, Turtel P, Bodian CA, etal. Patterns
of postoperative recurrence in stulizing and stenotic Crohn’s disease. A retrospective cohort
study of 71 patients. J Clin Gastroenterol. 1996;22(2):114–6. http://www.ncbi.nlm.nih.gov/
pubmed/8742649. [cited 2017 Jul 21].
16. Bernell O, Lapidus A, Hellers G. Risk factors for surgery and postoperative recurrence in
Crohn’s disease. Ann Surg. 2000;231:38. https://insights.ovid.com/pubmed?pmid=10636100.
[cited 2017 Jun 16].
17. Aratari A, Papi C, Leandro G, Viscido A, Capurso L, Caprilli R.Early versus late surgery for
ileo-caecal Crohn’s disease. Aliment Pharmacol Ther. 2007;26:1303–12.
18. Ramadas AV, Gunesh S, Thomas GAO, Williams GT, Hawthorne AB. Natural history of
Crohn’s disease in a population-based cohort from Cardiff (1986-2003): a study of changes in
medical treatment and surgical resection rates. Gut. 2010;59:1200.
19. Eshuis EJ, Peters CP, van Bodegraven AA, Bartelsman JF, Bemelman W, Fockens P, etal. Ten
years of iniximab for Crohn’s disease. Inamm Bowel Dis. 2013;19(8):1622–30. http://www.
ncbi.nlm.nih.gov/pubmed/23552767. [cited 2017 Jun 14].
20. Rungoe C, Langholz E, Andersson M, Basit S, Nielsen NM, Wohlfahrt J, et al. Changes in
medical treatment and surgery rates in inammatory bowel disease: a nationwide cohort study
1979–2011. Gut. 2014;63(10):1607–16. [cited 2017 Aug 14].
21. Cosnes J, Nion-Larmurier I, Beaugerie L, Afchain P, Tiret E, Gendre J-P.Impact of the increas-
ing use of immunosuppressants in Crohn’s disease on the need for intestinal surgery. Gut.
2005;54(2):237–41. http://www.ncbi.nlm.nih.gov/pubmed/15647188. [cited 2017 Jul 21].
22. Lamb BW, Brown KF, Nagpal K, Vincent C, Green JSA, Sevdalis N.Quality of care man-
agement decisions by multidisciplinary cancer teams: a systematic review. Ann Surg Oncol.
2011;18:2116–25.
23. Limketkai BN, Parian AM, Shah ND, Colombel J-F. Short bowel syndrome and intestinal
failure in Crohn’s disease. Inamm Bowel Dis. 2016;22(5):1209–18. http://www.ncbi.nlm.nih.
gov/pubmed/26818425. [cited 2017 Jun 29].
24. Shah SC, Colombel JF, Sands BE, Narula N.Systematic review with meta-analysis: muco-
sal healing is associated with improved long-term outcomes in Crohn’s disease. Aliment
Pharmacol Ther. 2016;43:317–33.
25. de Groof J, Bemelman W, Eshuis E, Gardenbroek T, Bossuyt P, Bosmans J, etal. OP015 Cost-
effectiveness of laparoscopic ileocecal resection versus iniximab treatment of terminal ileitis
in Crohn’s disease: the LIR!C TRIAL.J Crohns Colitis. 2017;11(Suppl_1):S9–S10. https://
insights.ovid.com/crohn-colitis/jcac/2017/02/001/op015-cost-effectiveness-laparoscopic-ileocecal/15/01337112. [cited 2017 Jul 7].
26. Rieder F, Zimmermann EM, Remzi FH, Sandborn WJ. Crohn’s disease complicated
by strictures: a systematic review. Gut. 2013;62(7):1072–84. https://doi.org/10.1136/
gutjnl-2012-304353. [cited 2017 Jun 30].
27. Burke JP, Mulsow JJ, O’Keane C, Docherty NG, Watson RWG, O’Connell PR.Fibrogenesis
in Crohn’s disease. Am J Gastroenterol. 2007;102(2):439–48. http://www.ncbi.nlm.nih.gov/
pubmed/17156147. [cited 2017 Jul 21].
K. A. T. G. M. Wasmann et al.
Соседние файлы в папке Библиотека им академика М.И. Перельмана
